ADD/ADHD

Top Story

FDA approves Mydayis for ADHD in adolescents

June 21, 2017

The FDA recently approved Mydayis, a once-daily mixed salts of a single-entity amphetamine product from Shire, for treatment of ADHD in individuals aged 13 years and older.

"The approval of Mydayis provides clinicians with another option to treat their patients with ADHD ages 13 and older," study researcher Andrew J. Cutler, MD, executive vice president and chief medical officer at Meridien, told Healio/Psychiatry. "In particular, there is a need for more approved medications for adults with ADHD.  Adults have long days, which require control of symptoms in several settings, such as home, school or work, and socially.  In clinical trials in adults with ADHD, Mydayis was shown to treat symptoms of ADHD for up to 16 hours.  Mydayis therefore provides clinicians with a new once a day treatment that can be effective for their appropriate patients with ADHD ages 13 and older."

In the Journals

Comorbid ADHD, conduct disorder explains link between autism, violence

June 21, 2017
Autism was associated with an increased risk for violent crime; however, the association was significantly attenuated by comorbid ADHD or conduct disorder, according to…
FDA News

FDA approves disintegrating Cotempla tablet for ADHD

June 20, 2017
Neos Therapeutics Inc. recently announced the FDA approved Cotempla XR-ODT, an extended-release orally disintegrating tablet, for the treatment of ADHD in children aged…
In the Journals

Minority children on Medicaid less likely to continue ADHD treatment

June 8, 2017
Black and Hispanic children enrolled in Medicaid are significantly more likely to discontinue pharmacological treatment for attention-deficit/hyperactivity disorder when…
CME Article

Determination of ADHD vs. Autism Spectrum Disorder

Psychiatric Annals, August 2012, Volume 42 Issue 8
1. Recognize that symptoms of inattention, impulsivity, and hyperactivity (attention-deficit/hyperactivity disorder…
More »
CME

Pediatric Hematology, Oncology, and Stem Cell Transplantation: July 2015

Keck School of Medicine of USC and Pediatric Annals

Hematology and oncology are areas where all pediatric trainees get exposure during residency. Yet, these few weeks in…
More »
Featured
ASM Microbe

ASM Microbe

Video
Meeting News Coverage

VIDEO: Expert discusses how to screen, diagnose and treat ADHD in preschool-aged children

September 14, 2015
More »
FDA News

FDA approves Mydayis for ADHD in adolescents

June 21, 2017
The FDA recently approved Mydayis, a once-daily mixed salts of a single-entity amphetamine product from Shire, for treatment of ADHD in individuals…

In the Journals

Comorbid ADHD, conduct disorder explains link between autism, violence

June 21, 2017
Autism was associated with an increased risk for violent crime; however, the association was significantly attenuated by comorbid ADHD or conduct…

FDA News

FDA approves disintegrating Cotempla tablet for ADHD

June 20, 2017
Neos Therapeutics Inc. recently announced the FDA approved Cotempla XR-ODT, an extended-release orally disintegrating tablet, for the treatment of…

In the Journals

Minority children on Medicaid less likely to continue ADHD treatment

June 8, 2017
Black and Hispanic children enrolled in Medicaid are significantly more likely to discontinue pharmacological treatment for…

FDA News

FDA approves generic Strattera for ADHD in children, adults

May 30, 2017
The FDA today approved the first generic of Strattera for treatment of ADHD in children and adults. In addition, Apotex Inc., Teva Pharmaceuticals…

In the Journals

Low-income children with chronic conditions at risk for significant costs without CHIP renewal

May 12, 2017
Low-income children with chronic conditions and their families could experience drastic cost increases for health care as much as

Behind the label: ADHD over 30 years

Infectious Diseases in Children, May 2017
To mark our 30th anniversary, Infectious Diseases in Children will be examining some of the chronic conditions and infectious diseases that have

Meeting News

Exposure to racism linked to higher rates of depression, ADHD in children

May 5, 2017
Children who experienced racial discrimination were more likely to exhibit anxiety and depression, as well as an increased risk for attention

AEVI-001 effective for adolescents with ADHD, contactin-4 mutation

May 1, 2017
Aevi Genomic Medicine recently presented updated responder data from the SAGA trial of AEVI-001, an oral nonstimulant, for adolescent ADHD. …

Dasotraline improves ADHD outcomes in the classroom

April 28, 2017
Recent findings indicated dasotraline, a dopamine and norepinephrine reuptake inhibitor, significantly improved ADHD outcomes in the classroom among…

More Headlines »
Advertisement
Advertisement